(alphaS)-alpha-Methyl-4-phenyl-1H-imidazole-2-methanamine
[CAS# 864825-23-0]

Identification

• Classification: Organic raw materials >> Heterocyclic compound >> Imidazoles
• Name: (alphaS)-alpha-Methyl-4-phenyl-1H-imidazole-2-methanamine
• Synonyms: (1S)-1-(5-phenyl-1H-imidazol-2-yl)ethanamine
• Molecular Formula: C₁₁H₁₃N₃
• Molecular Weight: 187.24
• CAS Registry Number: 864825-23-0
• EC Number: 809-885-5
• SMILES: C[C@@H](C1=NC=C(N1)C2=CC=CC=C2)N

Properties

• Solubility: Sparingly soluble (21 g/L) (25 °C), Calc.^*
• Density: 1.145±0.06 g/cm³ (20 °C 760 Torr), Calc.^*
• Index of Refraction: 1.607, Calc.^*
• Boiling Point: 422.1±28.0 °C (760 mmHg), Calc.^*
• Flash Point: 238.6±11.2 °C, Calc.^*

^* Calculated using Advanced Chemistry Development (ACD/Labs) Software.

Safety Data

• Hazard Symbols: GHS08 Warning
• Risk Statements: H315-H319-H335
• Safety Statements: P261-P264-P264+P265-P271-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501

Hazard Classification

Hazard	Class	Category Code	Hazard Statement
Eye irritation	Eye Irrit.	2	H319
Skin irritation	Skin Irrit.	2	H315
Specific target organ toxicity - single exposure	STOT SE	3	H335

Discovery and Applications

(alphaS)-alpha-Methyl-4-phenyl-1H-imidazole-2-methanamine is a chemical compound that has attracted attention due to its unique structural features and its potential applications in medicinal chemistry. This compound is classified as an imidazole derivative, which is a class of organic compounds that play an important role in biological systems. The molecular structure of (alphaS)-alpha-Methyl-4-phenyl-1H-imidazole-2-methanamine consists of an imidazole ring, a methyl group, a phenyl group, and a methanamine side chain. These functional groups contribute to its reactivity and biological activity, making it an interesting target for research in the field of drug discovery.

The discovery of (alphaS)-alpha-Methyl-4-phenyl-1H-imidazole-2-methanamine was part of an effort to develop novel compounds with potential pharmacological properties. Imidazole derivatives are known for their diverse biological activities, including antimicrobial, anti-inflammatory, and anticancer effects. The (alphaS)-configuration of the compound is important as it influences the stereochemical interactions with biological targets, which can impact the potency and specificity of the compound in various therapeutic contexts. The introduction of a methyl group at the alpha position of the imidazole ring further modulates the electronic properties and steric bulk, potentially enhancing the compound's binding affinity to its target.

In terms of application, (alphaS)-alpha-Methyl-4-phenyl-1H-imidazole-2-methanamine has been explored for its potential in treating a variety of diseases. Its structure suggests that it may interact with specific enzymes or receptors, which makes it a promising candidate for drug development. One area of interest is in the treatment of neurodegenerative diseases, where imidazole derivatives have been found to exhibit neuroprotective properties. Additionally, (alphaS)-alpha-Methyl-4-phenyl-1H-imidazole-2-methanamine could be explored for its role in modulating the immune system or as an adjunct in the treatment of cancer, where its ability to affect cell signaling pathways might offer therapeutic benefits.

The compound’s application in drug design is not limited to its standalone properties; it can also serve as a scaffold for the development of more complex molecules. By modifying the phenyl and methanamine groups, it is possible to fine-tune the pharmacokinetic and pharmacodynamic properties of the compound, improving its efficacy and reducing side effects. As a result, (alphaS)-alpha-Methyl-4-phenyl-1H-imidazole-2-methanamine may act as a starting point for developing a new class of therapeutic agents.

Further research into the synthesis, biological activity, and therapeutic potential of (alphaS)-alpha-Methyl-4-phenyl-1H-imidazole-2-methanamine is necessary to fully understand its capabilities and limitations. Its unique structural characteristics and potential for targeted drug development make it a compound of interest in modern medicinal chemistry.

References

2016. Eluxadoline. Pharmaceutical Substances.
URL: https://pharmaceutical-substances.thieme.com/ps/search-results?docUri=KD-05-0130